Intent to Sole Source - X10 VIALS of Floxuridine 500MG vials

The National Institutes of Health, Clinical Center (NIH-CC) issued this special notice of intent to negotiate a sole source contract with Cardinal Health, doing business as Specialty Pharmaceutical Services (JND Therapeutics). The acquisition is for 10 vials of Floxuridine 500MG for injections to support patient care at the Clinical Center in Bethesda, Maryland. This requirement is being processed under the statutory authority of 41 U.S.C. 253(c)(1), as implemented by FAR 6.302-1, identifying only one responsible source capable of satisfying the agency's needs.

The procurement is classified under NAICS 325412 Pharmaceutical Preparation Manufacturing and PSC 6505 Drugs and Biologicals. There is no set-aside designated for this action. Associated documentation includes a sole source justification and a quote from the intended vendor, both published on May 20, 2026.

Responses to this notice, identified by solicitation number NOI-CC-OLAO-26-006059, must be submitted by June 3, 2026, at 12:00 PM Eastern Standard Time. While this notice is not a request for proposal, the government will consider capability statements from responsible sources to determine if the requirement should be competed. The final decision to proceed with a non-competitive award rests solely within the discretion of the government.